We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
89 hedge funds and large institutions have $145M invested in Crescent Biopharma in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
69% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 13
32% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 22
18% more capital invested
Capital invested by funds: $123M → $145M (+$22.7M)
11% more funds holding
Funds holding: 80 → 89 (+9)
0.03% less ownership
Funds ownership: 0.84% → 0.81% (-0.03%)
46% less call options, than puts
Call options by funds: $387K | Put options by funds: $714K
Holders
89
Holders Change
+9
Holders Change %
+11.25%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
29
Reduced
22
Closed
13
Calls
$387K
Puts
$714K
Net Calls
-$327K
Net Calls Change
-$2.97M
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$8.06M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$3.15M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.85M |
| 4 |
CCM
CAAS Capital Management
New York
|
+$1.75M |
| 5 |
Two Sigma Investments
New York
|
+$1.64M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$11.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.3M |
| 3 |
BlackRock
New York
|
-$1.12M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$1.05M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$896K |
